08045479032

Parshva Agency
GST : 27AAAPR8475Q1ZQ

Our Products

Anti Cancer Medicine

Antidiabetic Medicine

Hormone Therapy Medicine

Anti HIV Medicine

Skin Cream

Monobenzone Cream USP 20% W-W

Pharma Vaccine Medicine

Anti Bacterial Medicine

Anti Malarial Medicine

Anti Viral Medicine

Hepatitis C Medicine

Osteoporosis Medicine

Antiarrhythmic Medicine

Mexiletine Hydrochloride Capsules IP

Erectile Dysfunction Medicine

SildenafilCitrate Tablets IP

Weight Management Medicine

Rheumatology Medicine

Skin Lightening Cream

Hydroquinone Plus Tretinoin Plus Mometasone Furoate Cream

Albumin Medicine

Hepatitis B Medicine

Entavir 1 mg Tablets

Neurology Medicine

Eye Drop

FDC Of Brinaolamide And Brimonidine Ophthalmic Suspension

Anti Fungal Medicine

Voriconazole Tablets IP 200 mg

Mycopenolic Acide Delayed tablets UPS 360Mg

Mycopenolic Acide Delayed tablets UPS 360Mg Specification

Dosage Form
Delayed-release tablet

Pacakaging (Quantity Per Box)
good quality

Indication
Prevention of organ transplant rejection

Salt Composition
Mycophenolic Acid 360 mg

Origin of Medicine
Imported or as per manufacturer specification

Drug Type
General Medicines

Ingredients
Mycophenolic Acid

Physical Form
Other

Function
Immunosuppressant

Recommended For
Patients requiring immunosuppressive therapy, especially post-organ transplant

Dosage
As directed by a healthcare professional

Dosage Guidelines
Swallow intact. Do not crush or chew. Follow medical advice.

Suitable For
Adults

Quantity
5000 Boxes

Storage Instructions
Store below 25C in a dry place, protect from light and moisture

Mycopenolic Acide Delayed tablets UPS 360Mg Trade Information

Minimum Order Quantity
50 Units

FOB Port
Maharashtra

Payment Terms
Paypal, Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID), Cheque, Telegraphic Transfer (T/T)

Supply Ability
500 Units Per Day

Delivery Time
1 Days

Sample Policy
If order is confirmed we will reimburse the sample cost

Packaging Details
good quality packaging safely delved 10TABLETS PER STRIP

Main Export Market(s)
Eastern Europe, Western Europe, Middle East, Africa, North America, Asia, Australia, South America, Central America

Main Domestic Market
All India

Certifications
Mycophenolic acid is an antimetabolite immunosuppressant indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant.

About Mycopenolic Acide Delayed tablets UPS 360Mg

Mycopenolic Acide Delayed tablets UPS 360Mg

Mycophenolic acid is an antimetabolite immunosuppressant indicated forprophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant.

Powerful Immunosuppressive Support

These delayed-release tablets are specifically designed for immunosuppressive therapy, targeting the prevention of organ transplant rejection in adults. Their unique formulation ensures gradual drug release, promoting stable blood concentrations and reduced gastrointestinal side effects. Only available by prescription, this product supports treatment regimens for post-transplant patients under medical supervision.

Convenience and Quality in Packaging

With a robust packaging standard, each tablet is individually blister-packed and securely housed in a carton box, providing integrity during storage and transport. Bulk orders start at 5,000 tablets, ideal for institutions or export. Quality assurance aligns with manufacturer and regulatory specifications, ensuring safety and authenticity from production through delivery.

FAQs of Mycopenolic Acide Delayed tablets UPS 360Mg:

Q: How should Mycophenolic Acid Delayed-Release Tablets USP 360 mg be taken?

A: The tablets should be swallowed whole, without crushing or chewing, and taken exactly as prescribed by your healthcare professional. Always follow medical instructions for dosing and never modify your regimen without consulting your doctor.

Q: What is the primary benefit of using this medication?

A: These tablets act as a potent immunosuppressant, significantly reducing the risk of organ transplant rejection. By modulating the immune system, they help maintain the success of the transplanted organ and improve long-term outcomes.

Q: When is this product recommended for use?

A: Mycophenolic Acid Delayed-Release Tablets USP 360 mg are recommended for adult patients who have undergone organ transplantation and need medication to prevent immune-mediated rejection of the new organ.

Q: What precautions should be followed while storing these tablets?

A: Tablets should be stored below 25C, in a dry place, and protected from light and moisture. Proper storage ensures the drugs stability and effectiveness throughout its 36-month shelf life.

Q: Where can I obtain this medication?

A: This product is available through licensed exporters, suppliers, and traders in India, typically in bulk orders. It requires a valid prescription and is distributed to authorized medical facilities or registered buyers.

Q: What is the minimum order quantity and how is it packaged?

A: The minimum order is 5,000 tablets, packaged in high-quality blister packs within carton boxes. Each box ensures safe transport and maintains product integrity until delivered to the end user.

Tell us about your requirement